STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – TCRR. MPB, FRBA
TCR2 Therapeutics Inc. (TCRR)
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am
Check Earnings Report
Company Research
Source: Accesswire
NEW YORK, NY / ACCESSWIRE / April 10, 2023 / Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:TCR² Therapeutics Inc. (NASDAQ:TCRR), relating to its proposed sale to Adaptimmune Therapeutics plc. Under the terms of the agreement, TCRR shareholders are expected to receive 1.5117 shares of Adaptimmune per share they own. Click here for more information: https://www.monteverdelaw.com/case/tcr2-therapeutics-inc. It is free and there is no cost or obligation to you. Mid Penn Bancorp, Inc. (NASDAQ:MPB), relating to its proposed acquisition of Brunswick Bancorp. Under the terms of the agreement, Brunswick shareholders are expected to receive either 0.598 shares of Mid Penn common stock or $18.00 in cash per share they own. Click here
Show less
Read more
Impact Snapshot
Event Time:
TCRR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCRR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCRR alerts
High impacting TCR2 Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics